Sort by 'likes'
Becoming a part of the solution: The Metastatic Prostate Cancer Project
The Broad Institute in Cambridge, Massachusetts, is one of the most sophisticated bioscience and biotechnology research centers in North America. It seeks to empower a revolution in biomedicine that will accelerate the speed at which we can conquer disease. The…
CLR 131 – A New Approach in Multiple Myeloma Treatment
CLR 131 is a targeted small-molecule that is being developed for the treatment of myeloma and lymphoma, as well as pediatric and head & neck cancers by Cellectar Biosciences. It works by delivering a radioactive, toxic compound directly to tumor…
Prevention and Management of PCOS Related Infertility – A Q&A Session
Polycystic ovary syndrome (PCOS) is a chronic disorder affecting 1 in 10 women of reproductive age. It is the primary cause of reduced frequency of ovulation and anovulation at the reproductive age and is commonly associated with infertility. The prevalence…
Discussing Myeloma Clinical Trials with Dr.Chari from Mount Sinai
Dr. Ajai-Chari from Mount Sinai Hospital, New York, a renowned myeloma expert, discusses Clinical Trials related to myeloma.
Unraveling Castleman Disease
Dr. David Fajgenbaum was diagnosed with a rare disorder that killed 35% of patients within five years of diagnosis. Dr. Fajgenbaum realised that he would have to lead the charge against his rare condition and we are talking to this…